Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last €198.00 EUR
Change Today -9.00 / -4.35%
Volume 27.1K
As of 1:30 PM 10/2/15 All times are local (Market data is delayed by at least 15 minutes).

sartorius ag-vorzug (SRT3) Snapshot

Previous Close
Day High
Day Low
52 Week High
09/30/15 - €223.10
52 Week Low
10/16/14 - €75.44
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for SARTORIUS AG-VORZUG (SRT3)

Related News

No related news articles were found.

sartorius ag-vorzug (SRT3) Related Businessweek News

No Related Businessweek News Found

sartorius ag-vorzug (SRT3) Details

Sartorius Aktiengesellschaft provides laboratory and process technologies and equipment primarily in Europe, North America, and the Asia Pacific. The company operates through Bioprocess Solutions, and Lab Products & Services segments. The Bioprocess Solutions segment offers products, technologies, and services ranging from fermentation, cell cultivation, filtration, and purification to media storage and transportation for the biopharmaceutical industry. It offers filters for liquids, air/gas filters, filter housings, filter integrity testing products, and OEM membranes; single-use bioprocess bags, containers, mixing systems, aseptic transfer systems, freeze and thaw systems, and tubing dis-/connectors; crossflow holders and systems, crossflow filters, membrane chromatography, clarification filters, virus filters, UV-C inactivation systems, and endonuclease; process analyzers, process control tools, microbiology products, and chemometric software; and media USP, media and buffer DSP, bioreactors/fermentors, and configurable single-use systems. The Lab Products & Services segment provides laboratory instruments, such as lab balances, pipettes, and laboratory water purification systems; and consumables, including laboratory filters and pipette tips. Its products include OEM weigh cells, mass comparators and metrology, weights/weight sets, paint mixing solutions, microbiology products, and moisture analyzers; lab water systems; bioreactors/fermentors, shakers/incubators, cell culture disposables, and centrifuges; and filters, ultrafiltration and membrane chromatography products, virus purification kits, diagnostic membranes and arrays, and blotting membranes. This segment also offers instrument and training services. It serves research and quality assurance laboratories of the pharmaceutical, chemical, and food industries. Sartorius Aktiengesellschaft was founded in 1870 and is headquartered in Goettingen, Germany.

5,875 Employees
Last Reported Date: 07/22/15
Founded in 1870

sartorius ag-vorzug (SRT3) Top Compensated Officers

Chairman of Executive Board and Group Chief E...
Total Annual Compensation: €1.0M
Member of the Executive Board
Total Annual Compensation: €615.0K
Member of the Executive Board
Total Annual Compensation: €435.0K
Compensation as of Fiscal Year 2014.

sartorius ag-vorzug (SRT3) Key Developments

Sartorius Reports Consolidated Earnings Results for the Second Quarter and Six Months Ended June 30, 2015; Raises Earnings Guidance for the Full Year of 2015

Sartorius reported consolidated earnings results for the first half of 2015. The company closed the first half of 2015 with significant double-digit gains in order intake, sales revenue and earnings. Sales climbed 15.9% in constant currencies; the reported figure, 26.6%. Operating profit also soared 42.8%; its respective margin after six months was 22.6%. Sales revenue also grew significantly by 15.9%, attaining €535.3 million after €423.0 million in the prior-year reporting period. The company significantly increased its underlying EBITDA by 42.8% to €121.1 million. This was due to strong development of sales and positive currency effects. Earnings contributed by the Bioprocess Solutions Division climbed to €97.8 million. The Lab Products & Sales Division also improved its profitability, reporting an underlying EBITDA of €23.4 million following on €18.4 million a year ago. Group EBIT, including extraordinary losses of €3.8 million, depreciation and amortization, was €90.8 million, reflecting a gain of 56.5%. Relevant net profit for the group surged from €29.3 million to €47.8 million. Consolidated earnings per ordinary share were €2.80 compared to €1.71 a year ago. For the quarter, the company reported net profit attributable to shareholders for the second quarter of EUR 27.2 million, or EUR 1.59 per share compared to EUR 11.7 million, or EUR 0.69 per share, for the same quarter ended June 30, 2014. Sales revenue for the second quarter ended June 30, 2015 was EUR 277.3 million, compared to EUR 219.9 million for the same quarter ended June 30, 2014. Based on the company’s positive business performance, management raised and specified its sales and earnings guidance for the full year of 2015. For the group, the company now expects sales to grow approx. 12% in constant currencies. This figure includes revenue of around 1 percentage point from recent acquisition (previous forecast without acquisitions: approx. 6% to 9%). The company's underlying EBITDA margin is forecasted to reach around 22.5%; previously, around 22.0% was anticipated. The company continues to plan on investing around 10% of its sales revenue.

Sartorius Aktiengesellschaft, H1 2015 Earnings Call, Jul 21, 2015

Sartorius Aktiengesellschaft, H1 2015 Earnings Call, Jul 21, 2015

Sartorius Aktiengesellschaft Presents at 12th Annual Goldman Sachs European Medtech and Healthcare Services Conference, Sep-09-2015

Sartorius Aktiengesellschaft Presents at 12th Annual Goldman Sachs European Medtech and Healthcare Services Conference, Sep-09-2015 . Venue: London, United Kingdom.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SRT3:GR €198.00 EUR -9.00

SRT3 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
CLARCOR Inc $48.02 USD +0.76
Donaldson Co Inc $28.14 USD +0.39
ESCO Technologies Inc $35.32 USD +0.09
Mettler-Toledo International Inc $290.21 USD +6.02
Pentair PLC $51.35 USD +1.80
View Industry Companies

Industry Analysis


Industry Average

Valuation SRT3 Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow 18.2x
TEV/Sales 1.3x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SARTORIUS AG-VORZUG, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at